GleamWall
中文EN

GEHC GE HealthCare Technologies Inc.

X-Ray Apparatus & Tubes & Related Irradiation Apparatus · Nasdaq · SEC CIK 1932393 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY6.9%
TTM net income YoY-2.8%
TTM EPS YoY-2.1%
Revenue 3-yr CAGR3.9%
Net income 3-yr CAGR7.8%

Margins

Gross margin39.9%
Operating margin13.3%
Net margin10.0%
FCF margin8.7%
EBITDA margin14.8%

Returns

ROE19.9%
ROA5.8%
ROIC (approx.)13.2%
Asset turnover0.58x

Leverage & solvency

Liabilities / assets69.1%
Debt / equity0.86x
Current ratio1.30x
Interest coverage6.60x

Cash quality & payout

Operating cash flow / net income1.12x
Accruals ratio-0.7%
Payout ratio3.0%
Capex / revenue2.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$5.51B$5.29B$5.13B$5.70B$5.14B$5.01B$4.78B$5.32B
Gross profit$2.22B$2.18B$1.98B$2.26B$1.99B$1.99B$2.01B$2.27B
R&D expense$320.00M$323.00M$345.00M$323.00M$292.00M$302.00M$344.00M$344.00M
SG&A expense$1.10B$1.12B$1.12B$1.11B$1.04B$1.03B$1.04B$1.13B
Operating income$805.00M$739.00M$515.00M$827.00M$653.00M$654.00M$629.00M$801.00M
Interest expense$122.00M$114.00M$96.00M$105.00M$111.00M$113.00M$110.00M$121.00M
Pretax income$752.00M$693.00M$505.00M$821.00M$643.00M$613.00M$692.00M$834.00M
Income tax$129.00M$119.00M$94.00M$219.00M$179.00M$113.00M$104.00M$96.00M
Net income$615.00M$561.00M$389.00M$589.00M$446.00M$486.00M$564.00M$721.00M
EBITDA$886.00M$815.00M$593.00M$901.00M$728.00M$727.00M$695.00M$866.00M
EPS (basic)1.361.240.85—0.981.061.23—
EPS (diluted)1.361.240.85—0.981.061.23—
Dividends declared per share0.040.040.040.040.070.000.040.04
Weighted avg. shares (diluted)453.00M454.00M457.00M—457.00M458.00M459.00M—
Balance sheet
Cash & equivalents$2.83B$2.08B$2.26B$4.49B$4.03B$3.77B$2.48B$2.89B
Inventory$2.63B$2.48B$2.35B$2.23B$2.30B$2.28B$2.16B$1.94B
Current assets$11.49B$10.50B$10.43B$12.50B$11.89B$11.31B$9.73B$9.90B
Goodwill$15.14B$15.10B$15.06B$13.49B$13.44B$13.42B$13.37B$13.14B
Intangibles$1.81B$1.89B$1.91B$1.13B$1.16B$1.22B$1.24B$1.08B
Total assets$38.37B$37.25B$37.12B$36.91B$36.13B$35.50B$33.59B$33.09B
Current liabilities$8.81B$8.30B$8.53B$9.11B$10.07B$9.75B$9.97B$9.55B
Short-term debt$2.00M$2.00M$2.00M$502.00M$2.00B$2.00B$2.00B$1.50B
Long-term debt$9.97B$10.09B$10.13B$9.49B$8.28B$8.27B$6.76B$7.45B
Total debt$9.97B$10.09B$10.13B$10.00B$10.28B$10.27B$8.76B$8.95B
Total liabilities$26.51B$26.03B$26.23B$26.31B$25.91B$25.55B$24.17B$24.44B
Shareholders' equity$11.61B$10.97B$10.67B$10.38B$9.99B$9.71B$9.19B$8.45B
Net debt$7.15B$8.01B$7.87B$5.50B$6.25B$6.51B$6.28B$6.06B
Cash flow statement
Operating cash flow$907.00M$168.00M$290.00M$1.05B$593.00M$94.00M$250.00M$913.00M
Capital expenditure$114.00M$100.00M$178.00M$134.00M$110.00M$86.00M$152.00M$102.00M
Free cash flow$793.00M$68.00M$112.00M$916.00M$483.00M$8.00M$98.00M$811.00M
Investing cash flow-$111.00M-$115.00M-$2.50B-$269.00M-$148.00M-$223.00M-$407.00M-$240.00M
Financing cash flow-$40.00M-$236.00M$21.00M-$293.00M-$165.00M$1.36B-$286.00M-$1.28B
Depreciation & amortization$81.00M$76.00M$78.00M$74.00M$75.00M$73.00M$66.00M$65.00M
Stock-based compensation$36.00M$45.00M$35.00M$36.00M$38.00M$34.00M$22.00M$33.00M
Dividends paid$16.00M$16.00M$16.00M$16.00M$16.00M$16.00M$16.00M$14.00M
Share buybacks$0$200.00M$100.00M$0$100.00M$100.00M$0$0

Free plan shows the latest 8 periods; Pro shows all 19 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.